Etest for Antifungal Suscepttibility Testing

FDA 510(k) K040560 · Ab Biodisk

Substantially Equivalent

510(k) numberK040560

Submission

Device name
Etest for Antifungal Suscepttibility Testing
Applicant
Ab Biodisk
Solna, SE
Received
March 3, 2004
Decision date
July 27, 2004
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
NGZ – Susceptibility Test Plate, Antifungal
Device class
Class II (moderate risk)
Regulation
21 CFR 866.1640
Specialty
Microbiology

The device is an in vitro diagnostic device intended for use in determining quantitative susceptibility of Candida species to various antifungal agents diluted in varying concentration in a microtiter plate format.

Other 510(k)s with product code NGZ

510(k)DeviceApplicantDecision
K243738The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of…NGZ · Traditional Thermo Fisher Scientific02/27/2025SE
K232967VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)NGZ · Traditional bioMerieux, Inc.06/12/2024SE
K232963VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)NGZ · Traditional bioMerieux, Inc.06/07/2024SE
K231433The Sensititre YeastOne Susceptibility System with Rezafungin in the dilution range of…NGZ · Traditional Thermo Fisher Scientific08/31/2023SE
K221198Sensititre YeastOne Susceptibility System with Fluconazole in the dilution range of…NGZ · Traditional Thermo Fisher Scientific03/10/2023SE
K221899The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of…NGZ · Traditional Thermo Fisher Scientific01/20/2023SE
K211539Sensititre YeastOne Susceptibility System with Voriconazole in the dilution range of…NGZ · Traditional Thermo Fisher Scientific12/15/2021SE
K181368VITEK 2 AST-YS Micafungin (<=0.06 - =>8 µg/mL)NGZ · Special bioMerieux, Inc.06/20/2018SE
K151923VITEK 2 AST-Yeast Micafungin (0.06-8 mcg/mL)NGZ · Traditional bioMerieux, Inc.03/25/2016SE
K151817VITEK 2 AST-YS Caspofungin <=0.125 - >=8 ug/mLNGZ · Traditional bioMerieux, Inc.02/18/2016SE

More from bioMerieux, Inc.

510(k)DeviceDecision
K081325Etest Doripenem - Antimicrobial Susceptibility Test - Mic at 0.002-32 Ug/MlJWY · Traditional 07/24/2008SE
K052366Etest Tigecycline Gram Positive and Gram Negative Aerobic Bacteria, Streptococcus Spp.…JWY · Traditional 10/13/2005SE
K042392DaptomycinJWY · Traditional 12/13/2004SE
K042390Etest for GemifloxacinJWY · Traditional 11/19/2004SE
K021445Etest Cefditoren for S. Pneumoniae and H. InfluenzaeJWY · Traditional 06/06/2002SE
K020748Etest ErtapenemJWY · Traditional 04/29/2002SE
K010363Etest MeropenemJWY · Traditional 04/09/2001SE
K002139Etest LinezolidLTX · Traditional 11/08/2000SE
K001547Etest Esbl Ct/Ctl Strip; Etest Esbl Tz/Tzl StripJWY · Traditional 08/07/2000SE
K000596Etest GatifloxacinJWY · Traditional 05/22/2000SE

Questions and answers

When was Etest for Antifungal Suscepttibility Testing cleared by the FDA?

Etest for Antifungal Suscepttibility Testing (K040560) received a 510(k) decision of Substantially Equivalent on July 27, 2004, 146 days after the submission was received.

What is the product code of K040560?

The FDA product code is NGZ – Susceptibility Test Plate, Antifungal, a Class II (moderate risk) device regulated under 21 CFR 866.1640.